Considering the fact that higher expression of IL-6 is evident in cancerous tissues than in adjacent noncancerous tissues in early-stage cervical cancer patients [36], and our observation that KP decreases EGF-induced IL-6 production and secretion, it is reasonable to imagine that KP may hamper cancer development. The gene discussed is EGF; the disease is cervical carcinoma.